Trenbolone Acetate (Tren Ace)
Tren A · Tren Ace
Trenbolone acetate is a potent injectable anabolic-androgenic steroid (AAS), a 19-nortestosterone (nandrolone) derivative with a 9,11-double bond that prevents aromatization and sharply increases androgen receptor binding affinity. The acetate ester gives it a short half-life (~48 hours), which requires frequent injections but also allows rapid clearance if side effects emerge. It was originally developed in the 1960s for veterinary use as a cattle growth promoter (marketed as Finaplix) and has never been FDA-approved for human use.
Inject EOD for stable blood levels given the ~48 hour half-life. Many advanced users inject daily at half the EOD dose for even smoother levels. Rotate injection sites (glutes, quads, delts, ventroglute). Always with a testosterone base. Have cabergoline on hand for potential progesterone-driven side effects.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
Trenbolone binds the androgen receptor (AR) with roughly 3-5 times the affinity of testosterone, driving potent protein synthesis and nitrogen retention in skeletal muscle. The 9,11-double bond blocks aromatase activity, so it cannot convert to estrogen - eliminating estrogenic side effects like water retention and gynecomastia from trenbolone itself, though it does bind the progesterone receptor.
As a 19-nor compound it suppresses endogenous testosterone production strongly and rapidly via negative feedback on the hypothalamic-pituitary-testicular (HPT) axis, requiring a testosterone base during every cycle. Trenbolone also exhibits significant glucocorticoid receptor antagonism, reducing cortisol-driven catabolism - part of why it produces such dry, hard muscle appearance.
Unlike 17-alpha-alkylated orals, trenbolone is not hepatotoxic in the classical sense, but its metabolites are renally excreted and have been associated with kidney stress markers. The acetate ester requires cleavage by plasma esterases to release free trenbolone, with peak serum levels 1-2 days post-injection.
What to expect
First 7-14 days: sharp increase in training aggression, noticeable night sweats, sleep quality often degrades. Strength gains already appreciable by week 2.
Weeks 3-5: signature hardening effect visible, dry muscle appearance, vascularity increases, cardio capacity drops noticeably.
Weeks 6-8: peak physique effect. Side effect burden is cumulative - most users cycle off at 8 weeks to let the body reset before considering another run.
Evidence
References for this compound are being re-checked against their source records. We are not showing them until each one is confirmed to support the claim it sits under.
Side effects & safety
Commonly reported
- Night sweats and sleep disruption
- Increased resting heart rate and blood pressure
- Suppressed endogenous testosterone (strong and rapid)
- Reduced cardio capacity (shortness of breath during cardio)
- Increased aggression and irritability (tren rage)
- Oily skin and acne flare
Less common & notes
- Hair loss acceleration in genetically predisposed users, libido changes (up or down), gynecomastia from progesterone receptor activity (respond to cabergoline not aromatase inhibitors), dark urine from metabolites (common and benign), kidney stress markers elevation, significant hematocrit rise, anxiety and panic attacks, vivid dreams and nightmares, depression in some users particularly post-cycle.
- Rare but serious: significant cardiovascular strain, renal dysfunction with prolonged high-dose use, neuropsychiatric crises.
Pharmacokinetics
Post-injection
IM injection - effectively 100% after ester cleavage
Per injection - supports EOD or daily dosing
Hepatic metabolism, renal excretion of metabolites (characteristic dark urine color).
Storage. Store at controlled room temperature (15-30°C / 59-86°F). Protect from light. Do not refrigerate - oil solutions can become difficult to draw if cold. Keep out of reach of children and in a locked location. Schedule III controlled substance in the United States.
Regulatory status
Schedule III controlled substance in the United States under the Anabolic Steroids Control Act of 1990. Never FDA-approved for human use. Originally marketed as Finaplix for veterinary cattle implants. No legal human prescription source in the United States. Internationally classified as a controlled substance in most jurisdictions.
Put it to work
Calculate, log & track
Open Trenbolone Acetate (Tren Ace) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Trenbolone Acetate (Tren Ace) in the app →Go deeper
The guide & community
The complete Trenbolone Acetate (Tren Ace) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗